Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: To all: I've noticed that some posters are asking

Thank you for your reply. So we agree on a lot, but not on the stock buy-back.

Perhaps I'm more of the opinion that a settlement with the Js is coming, and that if by some chance we do end up in court, and lose, it's basically game over. Yes, PTSC could manage to survive, maybe even prosper with the resources available. And yes, our team would likely appeal the decision. Will YOU be sticking around to watch THAT unfold, or just take your lumps? I'd be gone.

With this mindset, and confidence that we will prevail, the buy-back is the way to go. Yes it would bolster the PPS, yes it would demonstrate confidence, but it would be MONEY IN THE BANK. That's where it differs so much from a dividend. And when we prevail, what's the ROI? Any better returns available out there - over the next month? And again, if we don't prevail, will it have mattered that much?

JMHO, and I definitely KNOW nuttin'!

SGE

Share
New Message
Please login to post a reply